Find a Tender
complete
Official procurement procedure
Purchase of Nanobodies and epitope mapping for grant funded project
No classification published
Location not published
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: MHRA: "Purchase of Nanobodies and epitope mapping for grant funded project". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
| Contracting Authority | MHRA | Scope & Categories | Not published | Submission Window | complete No deadline published |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | Not published |
Bidder Intelligence · Authority Profile: MHRA
Market Analytics
Derived from OCDS awards & bid statistics
Published history for MHRA. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Competition Density
5.7Bids / Report
Supplier ConcentrationHigh Concentration
Parker Air Conditioning LtdTop vendor: 71.4% of attributable valuePayment Terms
Check noticePublished terms
Coverage: 34 active published awards; 3 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Historical Awarded Suppliers With This Authority:
| Supplier Name | Historic Awards | Attributable GBP Value |
|---|---|---|
| Parker Air Conditioning Ltd | 1 win | £300,000 |
| Spirax Sarco Limited | 1 win | £90,000 |
| Honeyman Water Limited | 1 win | £30,187 |
Procedure terms
Contracting AuthorityMHRA | Procedure methodNot published | Procurement categoryNot published |
Statuscomplete | Framework / DPSNot published | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published9 Dec 2025, 08:34 GMT | Last source update9 Dec 2025, 08:34 GMT | Recurring procurementNot published |
ClassificationNot published | ||
Delivery areaLocation not published | ||
OCIDocds-h6vhtk-05f155 | ||
What is being bought
The very important time constrains (before 20th of March 2026) attached to the awarded grant finance, for our specific objective, This supplier expertise with expressing our nanobody sequences in different formats, their speed, competitive pricing and MHRA’s prior in house validation of nanobody products made by this supplier , makes this supplier in our view the only provider that can realistically meet our request within the allocated timelines.
Protein production can be outsourced from several commercial entities, but the trade for companies that have relevant and ample experience in nanobody expression, at small scale, in a cost-effective and time-saving manner to fulfil our request is limited. Further, the timeline to complete the objectives of the project with the awarded grant finance translates into the inability to search, outsource, trial and validate the suitability of nanobodies produced by other suppliers unknown to MHRA, significantly narrowing feasible possibilities.
What changed
From the official release history
- Status changed to complete
9 Dec 2025, 08:34 GMT - Official notice release published
9 Dec 2025, 08:34 GMT - Buyer information updated
9 Dec 2025, 08:34 GMT
Lots and requirements (1)
Published by the contracting authority
- Lot 1 · #1Individual lot title not publishedcompletePublished valueNot publishedThe source published no individual title or description for this lot.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
9 Dec 2025, 08:34 GMT - Award active
Not published · Not published - Contract active
Signed 10 Nov 2025, 00:00 GMT · €80,000
Commercial outcome and competition
Awards Proteogenix SAS Not published · Not published · active |
Contracts Purchase of Nanobodies and epitope mapping for grant funded project €80,000 · signed 10 Nov 2025, 00:00 GMT · active Contract period: 11 Nov 2025, 00:00 GMT — 10 Nov 2026, 23:59 GMT |
Bid statisticsNo aggregate bid statistics published |
Buyer and organisations in this procedure
MHRA
Contracting authority GB-PPON-PJLJ-9824-VXPGDocuments (0)
Official links; attachments are not copied
No linked documents are published
Related procedures (0)
No related procedures published